N-Acetyl Semax Amidate vs Selank
Comparison of N-Acetyl Semax Amidate (Very Low evidence) and Selank (Moderate evidence).
Last updated: February 12, 2026
N-Acetyl Semax Amidate
Selank
Overview
N-Acetyl Semax Amidate and Selank are both studied in the peptide research space.
N-Acetyl Semax Amidate: A chemically modified version of Semax with N-terminal acetylation and C-terminal amidation designed to enhance peptide stability.
Selank: A synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, developed by Russian researchers and approved in Russia since 2009 for anxiety and neurasthenia.
Evidence Comparison
| Aspect | N-Acetyl Semax Amidate | Selank |
|---|---|---|
| Evidence Level | Very Low | Moderate |
| Human Studies | 0 | 5 |
| Preclinical Studies | 2 | 20 |
| Total Sources | 2 | 25 |
Key Differences
| Aspect | N-Acetyl Semax Amidate | Selank |
|---|---|---|
| Category | Cognitive | Cognitive |
| Evidence Strength | Very Low | Moderate |
| Total Sources | 2 | 25 |
| Human Studies | 0 | 5 |
Summary
- N-Acetyl Semax Amidate: Very Low evidence with 2 total sources (0 human)
- Selank: Moderate evidence with 25 total sources (5 human)
This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.
View Full Dossiers
Stay Updated on Peptide Comparisons
Get notified when we publish new comparison dossiers and evidence reviews.
No spam. Unsubscribe anytime.
Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.